"During the year (FY20), we have further strengthened our presence in the vaccines segment through the acquisition of RD assets from Profectus Biosciences through Auro Vaccines. Using those RD assets, the team is working on developing several viral vaccines, including a vaccine for COVID-19," it said.Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding
"During the year (FY20), we have further strengthened our presence in the vaccines segment through the acquisition of RD assets from Profectus Biosciences through Auro Vaccines. Using those RD assets, the team is working on developing several viral vaccines, including a vaccine for COVID-19," it said.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment